Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank50
3Y CAGR+2.2%
5Y CAGR-33.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+2.2%/yr
vs +9.3%/yr prior
5Y CAGR
-33.2%/yr
Recent acceleration
Acceleration
-7.1pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $17.47M | -66.1% |
| 2024 | $51.47M | +137.7% |
| 2023 | $21.66M | +32.5% |
| 2022 | $16.35M | +36.9% |
| 2021 | $11.94M | -90.9% |
| 2020 | $130.98M | +1184.7% |
| 2019 | $10.20M | -11.0% |
| 2018 | $11.45M | +39.2% |
| 2017 | $8.23M | -78.3% |
| 2016 | $37.89M | - |